Garry Neil
Overview
Garry Neil received an average of $1M in total compensation, including $446K in salary, at Avalo Therapeutics between 2021 and 2022.
Source: SEC filing on October 19, 2023.
Related executives
We found 16 more executives who work or worked at Avalo Therapeutics.
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
H Wilkins
Avalo Therapeutics
Chief Medical Officer
Simon Pedder
Avalo Therapeutics
Chairman
Pericles Calias
Avalo Therapeutics
Chief Scientific Officer
Joseph Miller
Avalo Therapeutics